Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v3-EN
Language French English
Date Updated 2019-09-13 2019-09-13
Drug Identification Number 02256754 02256754
Brand name TIAZAC XC TIAZAC XC
Common or Proper name TIAZAC XC TIAZAC XC
Company Name BAUSCH HEALTH, CANADA INC. BAUSCH HEALTH, CANADA INC.
Ingredients DILTIAZEM HYDROCHLORIDE DILTIAZEM HYDROCHLORIDE
Strength(s) 240MG 240MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size n/a n/a
ATC code C08DB C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2019-09-12 2019-09-12
Actual start date
Estimated end date 2019-09-30
Actual end date 2019-09-11
Shortage status Avoided shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments